2.1 = | 1.730 Cit. to date |
842 Docs. to date |
Updated monthly
Balraj Singh, Sarah Ayad, Parminder Kaur, Ro-Jay Reid, Sachin Gupta , Michael Maroules
2021-03-15
Views: 1058
HTML: 173
PDF: 444
|
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19). COVID-19 usually presents with respiratory symptoms but can affect multiple organ systems. A wide spectrum of complications can occur depending upon the comorbidities of patients. There is limited literature available regarding the presentation and outcome of COVID-19 in chronic lymphocytic leukaemia (CLL) patients. We report 2 cases of COVID-19-induced hyperleucocytosis (WBC count >100,000/?l) in CLL patients.
Noel Lorenzo-Villalba, Abrar-Ahmad Zulfiqar, Marc Auburtin, Marie Helene Schuhmacher, Alain Meyer, Yasmine Maouche, Olivier Keller, Emmanuel Andres
2020-05-07
Views: 1947
HTML: 4047
PDF: 733
|
We report three cases of severe thrombocytopenia during COVID-19 infection associated with either cutaneous purpura or mucosal bleeding. The initial investigations ruled out other causes of thrombocytopenia. Two of the patients were treated with intravenous immunoglobulins and eltrombopag, while the third recovered spontaneously. A good clinical and biological response was achieved in all patients leading to hospital discharge.
Sabine Revuz, Nathalie Vernier, Leilah Saadi, Julien Campagne, Sophie Poussing, François Maurier
2020-06-09
Views: 1241
HTML: 317
PDF: 501
|
We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.
2.1 = | 1.730 Cit. to date |
842 Docs. to date |
Official Journal of the
European Federation of Internal Medicine
www.efim.org
Publisher: SMC media Srl
Via Giovenale, 7 - 20136 Milan - Italy
P.IVA 07626490960
info@ejcrim.com
www.ejcrim.com - ISSN: 2284-2594 - © EFIM 2014-2023, Published by SMC Media srl, Italy - Privacy policy